Literature DB >> 22092847

The efficacy of silver dressings and antibiotics on MRSA and MSSA isolated from burn patients.

Steven L Percival1, John G Thomas, Will Slone, Sara Linton, Linda Corum, Tyler Okel.   

Abstract

In this study our objectives were (1) to investigate whether meticillin-resistant Staphylococcus aureus (MRSA) showed an increased tolerance to silver wound dressings compared with meticillin-sensitive S. aureus (MSSA); and (2) to evaluate the effects of bacterial phenotypic states of MRSA and MSSA, and pH, on the activity of silver wound dressings and two antibiotics, ampicillin and clindamycin. Twenty MRSA strains and 10 MSSA strains isolated from burns patients in South Africa were evaluated for their susceptibility to a silver alginate and a silver carboxymethyl cellulose wound dressing, employing a corrected zone of inhibition assay, conducted on Mueller Hinton agar and a poloxamer-based biofilm model. When exposed to the two silver dressings, all 30 S. aureus strains showed susceptibility. Possible enhanced antimicrobial efficacy of the silver dressings occurred when pH was lowered to 5.5, compared with a pH of 7.0. When all S. aureus were grown in the biofilm phenotypic state and exposed to both silver dressings and antibiotics, enhanced tolerance was noted. Susceptibility to silver was overall higher for MRSA when compared with MSSA. This study showed that the effect of pH and bacterial phenotypic state must be considered when the antimicrobial activity of silver wound dressings is being investigated. It is evident from the data generated that both pH and the bacterial phenotypic state are factors that induce changes that affect both antimicrobial performance and bacterial susceptibility. 2011 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092847     DOI: 10.1111/j.1524-475X.2011.00739.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  8 in total

Review 1.  Silver and Alginates: Role in Wound Healing and Biofilm Control.

Authors:  Steven L Percival; Sara M McCarty
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-07-01       Impact factor: 4.730

2.  The increased killing of biofilms in vitro by combining topical silver dressings with topical negative pressure in chronic wounds.

Authors:  Pedro Miguel Ds Valente; Anand Deva; Quan Ngo; Karen Vickery
Journal:  Int Wound J       Date:  2014-04-08       Impact factor: 3.315

3.  Killing bacteria within biofilms by sustained release of tetracycline from triple-layered electrospun micro/nanofibre matrices of polycaprolactone and poly(ethylene-co-vinyl acetate).

Authors:  Nour Alhusein; Paul A De Bank; Ian S Blagbrough; Albert Bolhuis
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

4.  The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds.

Authors:  Steven L Percival; John Thomas; Sara Linton; Tyler Okel; Linda Corum; Will Slone
Journal:  Int Wound J       Date:  2011-12-19       Impact factor: 3.315

5.  Chitin membranes containing silver nanoparticles for wound dressing application.

Authors:  Rita Singh; Durgeshwer Singh
Journal:  Int Wound J       Date:  2012-09-07       Impact factor: 3.315

Review 6.  Incorporation of Silver Nanoparticles in Hydrogel Matrices for Controlling Wound Infection.

Authors:  Harpreet Pangli; Saba Vatanpour; Shamim Hortamani; Reza Jalili; Aziz Ghahary
Journal:  J Burn Care Res       Date:  2021-08-04       Impact factor: 1.845

7.  In Vitro Assessment of the Antibacterial Potential of Silver Nano-Coatings on Cotton Gauzes for Prevention of Wound Infections.

Authors:  Federica Paladini; Cinzia Di Franco; Angelica Panico; Gaetano Scamarcio; Alessandro Sannino; Mauro Pollini
Journal:  Materials (Basel)       Date:  2016-05-25       Impact factor: 3.623

8.  Silver negative pressure dressing with vacuum-assisted closure of massive pelvic and extremity wounds.

Authors:  Herrick J Siegel; Diego F Herrera; Jason Gay
Journal:  Clin Orthop Relat Res       Date:  2014-03       Impact factor: 4.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.